Members of a Tunisian family with tumors on their hands, feet and eyes may provide helpful information for the treatment of squamous cell carcinoma, a common skin cancer.
Jun 24, 2015
0
27
A new therapeutic approach prevents the growth of metastatic tumors in mice by forcing cancer cells into a dormant state in which they are unable to proliferate. The study, published November 23 in the Journal of Experimental ...
Nov 23, 2021
0
42
University of Queensland researchers have discovered how to reverse drug resistance in skin and mouth squamous cell carcinomas.
Jun 28, 2018
0
85
Lidocaine—often used as a numbing agent for outpatient medical procedures—activates certain bitter taste receptors through two unique mechanisms that result in cancer cell death, according to researchers from the Perelman ...
Nov 22, 2023
0
180
A better survival outcome is associated with low blood levels of squamous cell carcinoma antigen, or absence of tumor invasion either into the space between the lungs and chest wall or into blood vessels of individuals with ...
Oct 24, 2014
0
0
Human skin is the body's largest organ, providing protection to muscles, bones, ligaments and organs. According to the Centers for Disease Control and Prevention, skin cancer is the most common type of cancer in the United ...
May 31, 2017
0
0
As an individual's level of vitamin D increases, the risk of nonmelanoma skin cancer (NMSC) seems to increase as well, although factors such as ultraviolet (UV) radiation exposure may complicate the relationship, according ...
Aug 15, 2011
0
0
A new study co-authored by a researcher starting her laboratory at the University of Kentucky Markey Cancer Center shows that in certain genetic situations, one non-small cell lung cancer subtype can change into another subtype.
Apr 14, 2017
0
34
Induced pluripotent stem cells made from patients with a form of blistering skin disease can be genetically corrected and used to grow back healthy skin cells in laboratory dishes, researchers at the Stanford University School ...
Nov 26, 2014
0
0
Patients with metastatic melanoma taking the recently approved drug vemurafenib (Zelboraf) responded well to the twice daily pill, but some of them developed a different, secondary skin cancer. Now, researchers at UCLA's ...
Jan 18, 2012
0
0
